Publications in collaboration with researchers from Hospital Vall d'Hebron (1)

2021

  1. SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade

    Nature Communications, Vol. 12, Núm. 1